Benchmark Holdings (BMK)

Sector:

Pharma and Biotech

 24.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 45.70
  • 52 Week Low: 17.70
  • Currency: UK Pounds
  • Shares Issued: 742.42m
  • Volume: 262,359
  • Market Cap: £178.18m
  • Beta: 0.01

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (£m) Pre-tax (£m) EPS Dividend
31-Dec-24 Q1 17.72 (7.07) (0.98)p n/a

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Sep-20 105.57 (22.57) (3.80)p n/a n/a n/a n/a 0.0%
30-Sep-21 125.06 (9.18) (1.93)p n/a n/a n/a n/a 0.0%
30-Sep-22 157.71 (21.38) (4.34)p n/a n/a n/a n/a 0.0%
30-Sep-23 103.96 (24.70) (3.21)p n/a n/a n/a n/a 0.0%
30-Sep-24 90.36 (45.92) (5.99)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Sep-25 79.70 (4.10) 26.63p 0.9 n/a n/a n/a 0.0%
30-Sep-26 83.70 11.30 1.10p 21.8 n/a -96% n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

BMK Market Data

Currency UK Pounds
Share Price 24.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 45.70
52 Week Low 17.70
Volume 262,359
Shares Issued 742.42m
Market Cap £178.18m
Beta 0.01

BMK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
67.21% above the market average67.21% above the market average67.21% above the market average67.21% above the market average67.21% above the market average
95.65% above the sector average95.65% above the sector average95.65% above the sector average95.65% above the sector average95.65% above the sector average
Price Trend
76.35% below the market average76.35% below the market average76.35% below the market average76.35% below the market average76.35% below the market average
52.17% below the sector average52.17% below the sector average52.17% below the sector average52.17% below the sector average52.17% below the sector average
Income Not Available
Growth
56.79% below the market average56.79% below the market average56.79% below the market average56.79% below the market average56.79% below the market average
79.31% below the sector average79.31% below the sector average79.31% below the sector average79.31% below the sector average79.31% below the sector average

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 1
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

BMK Dividends

No dividends found

Trades for 04-Jun-2025

Time Volume / Share Price
15:47 50,000 @ 23.92p
16:35 818 @ 24.00p
16:35 351 @ 24.00p
16:35 467 @ 24.00p
16:15 9,615 @ 23.85p

BMK Key Personnel

CFO Septima Maguire
CEO Trond Williksen
Chair Tripp Lane

Top of Page